These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 24962755)

  • 21. A thermostable messenger RNA based vaccine against rabies.
    Stitz L; Vogel A; Schnee M; Voss D; Rauch S; Mutzke T; Ketterer T; Kramps T; Petsch B
    PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006108. PubMed ID: 29216187
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting Vaccine-Induced Extrafollicular Pathway of B Cell Differentiation Improves Rabies Postexposure Prophylaxis.
    Haley SL; Tzvetkov EP; Meuwissen S; Plummer JR; McGettigan JP
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28148792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AAV-expressed G protein induces robust humoral and cellular immune response and provides durable protection from rabies virus challenges in mice.
    Liu C; Li J; Yao Q; Gao Z; Cheng Y; Zhou M; Tang Y; Sun L; Dai J; Cao G; Zhang XL; Zhang R
    Vet Microbiol; 2020 Mar; 242():108578. PubMed ID: 32122589
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A DNA vaccine that encodes rabies virus glycoprotein lacking transmembrane domain enhances antibody response but not protection.
    Gupta PK; Sharma S; Walunj SS; Patil AA; Rai A; Saini M
    Acta Virol; 2006; 50(2):87-92. PubMed ID: 16808325
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A rabies virus vectored severe fever with thrombocytopenia syndrome (SFTS) bivalent candidate vaccine confers protective immune responses in mice.
    Tian L; Yan L; Zheng W; Lei X; Fu Q; Xue X; Wang X; Xia X; Zheng X
    Vet Microbiol; 2021 Jun; 257():109076. PubMed ID: 33957572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Engineering of a recombinant trivalent single-chain variable fragment antibody directed against rabies virus glycoprotein G with improved neutralizing potency.
    Turki I; Hammami A; Kharmachi H; Mousli M
    Mol Immunol; 2014 Feb; 57(2):66-73. PubMed ID: 24091293
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression and solubilization of insect cell-based rabies virus glycoprotein and assessment of its immunogenicity and protective efficacy in mice.
    Ramya R; Mohana Subramanian B; Sivakumar V; Senthilkumar RL; Sambasiva Rao KR; Srinivasan VA
    Clin Vaccine Immunol; 2011 Oct; 18(10):1673-9. PubMed ID: 21813661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhancing comparative rabies DNA vaccine effectiveness through glycoprotein gene modifications.
    Osinubi MO; Wu X; Franka R; Niezgoda M; Nok AJ; Ogunkoya AB; Rupprecht CE
    Vaccine; 2009 Nov; 27(51):7214-8. PubMed ID: 19925956
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Toward the Development of a Pan-Lyssavirus Vaccine.
    Ben Hamed S; Myers JF; Chandwani A; Wirblich C; Kurup D; Paran N; Schnell MJ
    Viruses; 2024 Jul; 16(7):. PubMed ID: 39066269
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rabies virus-like particles expressed in HEK293 cells.
    Fontana D; Kratje R; Etcheverrigaray M; Prieto C
    Vaccine; 2014 May; 32(24):2799-804. PubMed ID: 24631077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Verification of the rabies virus glycoprotein lower limit of immunogenicity by serological assay.
    Moreira WC; Machado NS; Freitas JFS; Almeida AECC; Moura WC
    J Virol Methods; 2019 Feb; 264():31-37. PubMed ID: 30448319
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A sindbis virus replicon-based DNA vaccine encoding the rabies virus glycoprotein elicits immune responses and complete protection in mice from lethal challenge.
    Saxena S; Dahiya SS; Sonwane AA; Patel CL; Saini M; Rai A; Gupta PK
    Vaccine; 2008 Dec; 26(51):6592-601. PubMed ID: 18848857
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rabies virus glycoprotein and immune response pattern using recombinant protein or recombinant RNA viral vectors.
    Astray RM; Ventini DC; Boldorini VL; Silva FG; Rocca MP; Pereira CA
    Vaccine; 2014 May; 32(24):2829-32. PubMed ID: 24598721
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Virus-Like Vesicles Based on Semliki Forest Virus-Containing Rabies Virus Glycoprotein Make a Safe and Efficacious Rabies Vaccine Candidate in a Mouse Model.
    Zhang C; Tian Y; Chen C; Wang Z; Pei J; Lin C; Zhou M; Fu ZF; Zhao L
    J Virol; 2021 Sep; 95(20):e0079021. PubMed ID: 34346765
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunogenicity of multi-epitope-based vaccine candidates administered with the adjuvant Gp96 against rabies.
    Niu Y; Liu Y; Yang L; Qu H; Zhao J; Hu R; Li J; Liu W
    Virol Sin; 2016 Apr; 31(2):168-75. PubMed ID: 27068655
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of protective immunity by topic application of a recombinant adenovirus expressing rabies virus glycoprotein.
    Lees CY; Briggs DJ; Wu X; Davis RD; Moore SM; Gordon C; Xiang Z; Ertl HC; Tang DC; Fu ZF
    Vet Microbiol; 2002 Apr; 85(4):295-303. PubMed ID: 11856579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The induction of protective immune response in mice vaccinated by recombinant avian adenovirus CELO expressing glycoprotein G of the rabies virus].
    Shmarov MM; Tutykhina IL; Logunov DIu; Verkhovskai LV; Nedosekov VV; Tsybanov SZh; Novikov BV; Narodnitskiĭ BS; Gintsburg AL
    Zh Mikrobiol Epidemiol Immunobiol; 2006; (4):69-71. PubMed ID: 16941876
    [TBL] [Abstract][Full Text] [Related]  

  • 38. APRIL:TACI axis is dispensable for the immune response to rabies vaccination.
    Haley SL; Tzvetkov EP; Lytle AG; Alugupalli KR; Plummer JR; McGettigan JP
    Antiviral Res; 2017 Aug; 144():130-137. PubMed ID: 28619678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inactivated Recombinant Rabies Viruses Displaying Canine Distemper Virus Glycoproteins Induce Protective Immunity against Both Pathogens.
    da Fontoura Budaszewski R; Hudacek A; Sawatsky B; Krämer B; Yin X; Schnell MJ; von Messling V
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28148801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Matrix-M™ adjuvanted envelope protein vaccine protects against lethal lineage 1 and 2 West Nile virus infection in mice.
    Magnusson SE; Karlsson KH; Reimer JM; Corbach-Söhle S; Patel S; Richner JM; Nowotny N; Barzon L; Bengtsson KL; Ulbert S; Diamond MS; Stertman L
    Vaccine; 2014 Feb; 32(7):800-8. PubMed ID: 24380682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.